39:32Andriy Marusyk: "Embracing the complexity of the evolution of targeted therapy resistance"Advanced
18:32Anindita Chakrabarty: "Exploiting therapy-induced senescence as an evolutionary double-bind"Advanced
34:13Bob Gatenby: "Mathematical Modeling in Cancer Therapy - The Importance of After-Action Analysis"
15:57Charles D Kocher: "Enumerating optimal cancer treatment schedules across patient parameter space"
16:42Einar Bjarki Gunnarsson: "Optimal dosing of anti-cancer treatment under drug-induced plasticity"Advanced
30:30Erin George: "Rewriting the rules of recurrence: integrating evolution into ovarian cancer therapy"Advanced
14:38François de Kermenguy: "Radiation-Induced Lymphopenia: From Modeling Towards Mechanistic Learning"Advanced
15:33Jill Gallaher: "Adaptive therapy in advanced basal cell carcinoma driven by mathematical modelling"Advanced
15:15Joon-Hyun Song: "Microenvironmental Fluctuations Select between Storage-Effect and Plasticity"Advanced
15:27Kayode Olumoyin: "Modeling Adoptive Cell Therapy in Cancer Using Physics-Informed Neural Network"Advanced
14:38Kit Gallagher: "Predicting Treatment Outcomes from Adaptive Therapy - A New Mathematical Biomarker"Advanced
21:26M A Masud: "Developing a model-based pipeline for combination therapy cycling: KRAS mutated NSCLC"Advanced
15:24Marina Pérez Aliacar: "Incorporating phenotypic plasticity into MRI-informed GBM modeling"Advanced
16:56Mark Robertson-Tessi: "Applications of evolutionary therapy for individual patient care"Advanced
9:25Natalie Meacham: "An Inverse Problem to Recover Sensitivity to Treatment in Prostate Cancer"Advanced
16:57Nicholas Harbour: "Virtual Clinical Trials of BMP4 Differentiation Therapy in Glioblastoma"Advanced
14:44Noemi Andor: "Linking Nutrient Deprivation and Whole-Genome Duplication to Metastatic Timelines"Advanced
1:06:42Rob Noble: "Using mathematical models to support clinical trials of evolutionary cancer therapies"
14:21Sandhya Prabhakaran: "Evolutionary immunotherapy in NSCLC: Optimal dosing in adoptive cell therapy"Advanced